BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Muff-Luett M, Nester CM. The Genetics of Ultra-Rare Renal Disease. J Pediatr Genet 2016;5:33-42. [PMID: 27617140 DOI: 10.1055/s-0036-1572515] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Ozen A. CHAPLE syndrome uncovers the primary role of complement in a familial form of Waldmann's disease. Immunol Rev 2019;287:20-32. [PMID: 30565236 DOI: 10.1111/imr.12715] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
2 Rodriguez-Monguio R, Spargo T, Seoane-Vazquez E. Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients' health needs? Orphanet J Rare Dis 2017;12:1. [PMID: 28057032 DOI: 10.1186/s13023-016-0551-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 8.2] [Reference Citation Analysis]
3 Scherman D, Fetro C. Drug repositioning for rare diseases: Knowledge-based success stories. Therapie 2020;75:161-7. [PMID: 32164975 DOI: 10.1016/j.therap.2020.02.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Thurman JM, Frazer-Abel A, Holers VM. The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases. Arthritis Rheumatol 2017;69:2102-13. [PMID: 28732131 DOI: 10.1002/art.40219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]